← European Medicine Shortage Tracker · all medicines

Insulin glulisine frankfurt am main, germany shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Insulin glulisine frankfurt am main, germany currently has availability issues reported in 1 European register: Greece.

Limited availability  ATC A10AB06 · also listed as: INSULIN GLULISINE FRANKFURT AM MAIN, GERMANY · data refreshed 15 September 2026

Key facts

As of 15 September 2026, 1 of the 8 tracked registers list current availability issues for Insulin glulisine frankfurt am main, germany, covering 1 affected product presentation. The longest-running open report was filed in Greece on 2026-05-25 and has now been open for about 4 months. Where agencies state a cause, delivery delays lead with 1 of the 1 stated-cause reports. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. In the WHO ATC classification, Insulin glulisine frankfurt am main, germany is coded A10AB06 — a medicine acting on alimentary tract and metabolism — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇬🇷 GreeceLimited availability
INSULIN GLULISINE FRANKFURT AM MAIN, GERMANY
2026-05-252026-07-23Καθυστέρηση παράδοσης DIALOSA TABLET 3MG/TAB BTx 30 σε BLISTER Εναλλακregister ↗

Full report history (1 register entry)

Every individual register entry for Insulin glulisine frankfurt am main, germany in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇬🇷 GRINSULIN GLULISINE FRANKFURT AM MAIN, GERMANYLimited availability2026-05-252026-07-23Καθυστέρηση παράδοσης DIALOSA TABLET 3MG/TAB BTx 30 σε BLIST

Frequently asked

Is Insulin glulisine frankfurt am main, germany currently in shortage in Europe?

Yes. As of 15 September 2026, availability issues are reported in: Greece. Availability is national — a shortage in one country does not mean it is short everywhere.

Where does this Insulin glulisine frankfurt am main, germany availability data come from?

Directly from the official medicines-agency register that lists Insulin glulisine frankfurt am main, germany: EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Insulin glulisine frankfurt am main, germany — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/insulin-glulisine-frankfurt-am-main-germany/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Insulin glulisine frankfurt am main, germany availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/insulin-glulisine-frankfurt-am-main-germany/">Insulin glulisine frankfurt am main, germany shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Insulin glulisine frankfurt am main, germany: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 15 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.